These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 37700218)

  • 21. Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis.
    Yang B; Li X; Zhang W; Fan J; Zhou Y; Li W; Yin J; Yang X; Guo E; Li X; Fu Y; Liu S; Hu D; Qin X; Dou Y; Xiao R; Lu F; Wang Z; Qin T; Wang W; Zhang Q; Li S; Ma D; Mills GB; Chen G; Sun C
    Cell Rep Med; 2022 Dec; 3(12):100856. PubMed ID: 36543113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of artificial intelligence in the diagnosis and prognostic prediction of ovarian cancer.
    Zhou J; Cao W; Wang L; Pan Z; Fu Y
    Comput Biol Med; 2022 Jul; 146():105608. PubMed ID: 35584585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artificial intelligence applications in prostate cancer.
    Baydoun A; Jia AY; Zaorsky NG; Kashani R; Rao S; Shoag JE; Vince RA; Bittencourt LK; Zuhour R; Price AT; Arsenault TH; Spratt DE
    Prostate Cancer Prostatic Dis; 2024 Mar; 27(1):37-45. PubMed ID: 37296271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular cluster mining of high-grade serous ovarian cancer via multi-omics data analysis aids precise medicine.
    Cai D; Liu T; Fang J; Liu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):9151-9165. PubMed ID: 37178426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study.
    Lococo F; Boldrini L; Diepriye CD; Evangelista J; Nero C; Flamini S; Minucci A; De Paolis E; Vita E; Cesario A; Annunziata S; Calcagni ML; Chiappetta M; Cancellieri A; Larici AR; Cicchetti G; Troost EGC; Ádány R; Farré N; Öztürk E; Van Doorne D; Leoncini F; Urbani A; Trisolini R; Bria E; Giordano A; Rindi G; Sala E; Tortora G; Valentini V; Boccia S; Margaritora S; Scambia G
    BMC Cancer; 2023 Jun; 23(1):540. PubMed ID: 37312079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
    Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
    EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applications of artificial intelligence multiomics in precision oncology.
    Srivastava R
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):503-510. PubMed ID: 35796775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A denoised multi-omics integration framework for cancer subtype classification and survival prediction.
    Pang J; Liang B; Ding R; Yan Q; Chen R; Xu J
    Brief Bioinform; 2023 Sep; 24(5):. PubMed ID: 37594302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiomics dynamic learning enables personalized diagnosis and prognosis for pancancer and cancer subtypes.
    Lu Y; Peng R; Dong L; Xia K; Wu R; Xu S; Wang J
    Brief Bioinform; 2023 Sep; 24(6):. PubMed ID: 37889117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of Artificial Intelligence for Preoperative Diagnostic and Prognostic Prediction in Epithelial Ovarian Cancer Based on Blood Biomarkers.
    Kawakami E; Tabata J; Yanaihara N; Ishikawa T; Koseki K; Iida Y; Saito M; Komazaki H; Shapiro JS; Goto C; Akiyama Y; Saito R; Saito M; Takano H; Yamada K; Okamoto A
    Clin Cancer Res; 2019 May; 25(10):3006-3015. PubMed ID: 30979733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
    Olbrecht S; Busschaert P; Qian J; Vanderstichele A; Loverix L; Van Gorp T; Van Nieuwenhuysen E; Han S; Van den Broeck A; Coosemans A; Van Rompuy AS; Lambrechts D; Vergote I
    Genome Med; 2021 Jul; 13(1):111. PubMed ID: 34238352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiomics Analysis of Tumor Microenvironment Reveals Gata2 and miRNA-124-3p as Potential Novel Biomarkers in Ovarian Cancer.
    Gov E; Kori M; Arga KY
    OMICS; 2017 Oct; 21(10):603-615. PubMed ID: 28937943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging-AMARETTO: An Imaging Genomics Software Tool to Interrogate Multiomics Networks for Relevance to Radiography and Histopathology Imaging Biomarkers of Clinical Outcomes.
    Gevaert O; Nabian M; Bakr S; Everaert C; Shinde J; Manukyan A; Liefeld T; Tabor T; Xu J; Lupberger J; Haas BJ; Baumert TF; Hernaez M; Reich M; Quintana FJ; Uhlmann EJ; Krichevsky AM; Mesirov JP; Carey V; Pochet N
    JCO Clin Cancer Inform; 2020 May; 4():421-435. PubMed ID: 32383980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MMDAE-HGSOC: A novel method for high-grade serous ovarian cancer molecular subtypes classification based on multi-modal deep autoencoder.
    Wang HQ; Li HL; Han JL; Feng ZP; Deng HX; Han X
    Comput Biol Chem; 2023 Aug; 105():107906. PubMed ID: 37336028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiomics and artificial intelligence enabled peripheral blood-based prediction of amnestic mild cognitive impairment.
    Tatara Y; Yamazaki H; Katsuoka F; Chiba M; Saigusa D; Kasai S; Nakamura T; Inoue J; Aoki Y; Shoji M; Motoike IN; Tamada Y; Hashizume K; Shoji M; Kinoshita K; Murashita K; Nakaji S; Yamamoto M; Itoh K
    Curr Res Transl Med; 2023; 71(1):103367. PubMed ID: 36446162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applying Artificial Intelligence to Gynecologic Oncology: A Review.
    Mysona DP; Kapp DS; Rohatgi A; Lee D; Mann AK; Tran P; Tran L; She JX; Chan JK
    Obstet Gynecol Surv; 2021 May; 76(5):292-301. PubMed ID: 34032861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artificial intelligence in cancer pathology: Challenge to meet increasing demands of precision medicine.
    Lai B; Fu J; Zhang Q; Deng N; Jiang Q; Peng J
    Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37539741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Artificial Intelligence in Bulk and Single-Cell RNA-Sequencing Data to Foster Precision Oncology.
    Del Giudice M; Peirone S; Perrone S; Priante F; Varese F; Tirtei E; Fagioli F; Cereda M
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A journey from omics to clinicomics in solid cancers: Success stories and challenges.
    Mehrotra S; Sharma S; Pandey RK
    Adv Protein Chem Struct Biol; 2024; 139():89-139. PubMed ID: 38448145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor Microenvironment and the Role of Artificial Intelligence in Breast Cancer Detection and Prognosis.
    Malherbe K
    Am J Pathol; 2021 Aug; 191(8):1364-1373. PubMed ID: 33639101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.